Assessment and management of psoriasis: Summary of NICE guidance

BMJ (Online)

Volumn 345, Issue 7880, 2012, Pages

  Samarasekera, Eleanor ^a   Sawyer, Laura ^a   Parnham, Jill ^a   Smith, Catherine H ^b  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; METHOTREXATE;

CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ERYTHRODERMA; FEVER; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MALAISE; NATIONAL HEALTH ORGANIZATION; NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSORIASIS; PUSTULAR PSORIASIS; REVIEW; ULTRAVIOLET B RADIATION;

DISEASE MANAGEMENT; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; PSORIASIS; RISK ASSESSMENT;

EID: 84868031976     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e6712     Document Type: Review

References (14)

1. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM, for the Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2012; doi:10.1038/jid.2012.339.
2. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009; 61: 1373-8.
3. Ahlehoff O. Psoriasis and cardiovascular disease. Dan Med Bull. 2011; 58: B4347.
4. Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 2009; 145: 379-82.
5. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010; 146: 891-5.
6. Dubertret L, Mrowietz U, Ranki A, van de Kerkhof PC, Chimenti S, Lotti T, et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729-36.
7. National Institute for Health and Clinical Excellence. Psoriasis: the management of psoriasis. NICE, 2012. http://guidance.nice.org.uk/CG/Wave23/6.
8. Spuls PI, Lecluse LL, Poulsen ML, Bos JD, Stern RS, Nijsten T. How good are clinical severity and outcome measures for psoriasis? Quantitative evaluation in a systematic review. J Invest Dermatol 2010; 130: 933-43.
9. Ibrahim GH, Buch MH, Lawson C, Waxman R, Helliwell PS. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the psoriasis epidemiology screening tool (PEST) questionnaire. Clin Exp Rheumatol 2009; 27: 469-74.
10. National Collaborating Centre for Primary Care. Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. National Collaborating Centre for Primary Care, Royal College of General Practitioners, 2008. http://guidance.nice.org.uk/ CG67.
11. National Collaborating Centre for Primary Care. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. National Collaborating Centre for Primary Care, Royal College of General Practitioners, 2009. http://guidance.nice.org.uk/CG76.
12. Schofield J, Grindlay D, Williams H. Skin conditions in the UK: a health needs assessment. University of Nottingham, 2009.
13. NHS Scotland. Photonet national managed clinical network for phototherapy in Scotland. www.photonet.scot.nhs.uk/.
14. Eedy DJ, Griffiths CE, Chalmers RJ, Ormerod AD, Smith CH, Barker JN, et al. Care of patients with psoriasis: an audit of UK services in secondary care. Br J Dermatol 2009; 160: 557-64.